Robert Leo Murphy

Grants

Grants per year 1997 2004 2005 2008 2014 2028

• 11 Active
• 115 Finished

Grants per year

Search results

• Finished

  Prot# TMC125-C223: A Randomized, Controlled, Partially Blinded Phase IIb Dose-Finding Trial of TMC125, in HIV-1 Infected Subjects with Documented Genotypic Evidence of Resistance to Currently Available NNRTIs and With at Least Three Primary PI Mutations

  Murphy, R. L. (PD/PI)

  PPD Development, Tibotec Pharmaceuticals Ltd.

  7/20/04 → 8/8/07

  Project: Research project

• Prot# TMC125-C223: A Randomized, Controlled, Partially Blinded Phase IIb Dose-Finding Trial of TMC125, in HIV-1 Infected Subjects with Documented Genotypic Evidence of Resistance to Currently Available NNRTIs and With at Least Three Primary PI Mutations

  Murphy, R. L. (PD/PI)

  PPD Development, Tibotec Pharmaceuticals Ltd.

  7/20/04 → 8/8/07

  Project: Research project

• Prot# SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial Function

  Murphy, R. L. (Other)

  Abbott Laboratories

  4/4/04 → 11/4/06

  Project: Research project

• Prot# SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial Function

  Murphy, R. L. (Other)

  Abbott Laboratories

  4/4/04 → 11/4/06

  Project: Research project

• CIPRA

  Murphy, R. L. (PD/PI)

  Harvard University, National Institute of Allergy and Infectious Diseases

  3/1/04 → 2/28/06

  Project: Research project

• Rapid Expansion of Antiretroviral Therapy Programs (PEPFAR)

  Murphy, R. L. (PD/PI) & Taiwo, B. O. (Co-PD/PI)

  Harvard University, Health Resources and Services Administration

  3/1/04 → 2/28/09

  Project: Research project

• Rapid Expansion of Antiretroviral Therapy Programs (PEPFAR)

  Murphy, R. L. (PD/PI) & Taiwo, B. O. (Co-PD/PI)

  Harvard University, Health Resources and Services Administration

  3/1/04 → 2/28/09

  Project: Research project

• CIPRA

  Murphy, R. L. (PD/PI)

  Harvard University, National Institute of Allergy and Infectious Diseases

  3/1/04 → 2/28/06

  Project: Research project

• Prot# Tibotec TMC114-C202: A Phase II Randomized, Controlled, Partially Blinded, 48-Week Trial to Investigate Dose-Response of TMC114/RTV in 3-Class-Experienced, Multi PI-Experienced HIV-1 Infected Subjects

  Murphy, R. L. (PD/PI)

  Inveresk Research, Inc., Tibotec Pharmaceuticals Ltd.

  2/9/04 → 8/12/08

  Project: Research project

• Northwestern Adult AIDS Clinical Trials Unit

  Murphy, R. L. (PD/PI)

  National Institute of Allergy and Infectious Diseases

  1/1/04 → 12/31/07

  Project: Research project

• Northwestern Adult AIDS Clinical Trials Unit

  Murphy, R. L. (PD/PI)

  National Institute of Allergy and Infectious Diseases

  1/1/04 → 12/31/07

  Project: Research project

• Regional Center for Excellence for Bioterrorism: Molecular Analysis and Intervention: Emergency Response Plan Component

  Murphy, R. L. (PD/PI), Stosor, V. (Co-PD/PI), Wolinsky, S. M. (Co-PD/PI), Zembower, T. R. (Co-PD/PI) & Zembower, T. R. (Co-Investigator)

  The University of Chicago, National Institute of Allergy and Infectious Diseases

  9/4/03 → 2/28/09

  Project: Research project

• Regional Center for Excellence for Bioterrorism: Molecular Analysis and Intervention: Emergency Response Plan Component

  Murphy, R. L. (PD/PI), Stosor, V. (Co-PD/PI), Wolinsky, S. M. (Co-PD/PI), Zembower, T. R. (Co-PD/PI) & Zembower, T. R. (Co-Investigator)

  The University of Chicago, National Institute of Allergy and Infectious Diseases

  9/4/03 → 2/28/09

  Project: Research project

• Prot# SILCAAT: A Phase III Multicenter Randomized Study of the Biological and Clinical Efficacy of Subcutaneous Recombinant, Human Interleukin-2 in HIV-Infected Patients with Low CD4+ Counts Under Active Antiretroviral Therapy (the "SILCAAT Trial")

  Murphy, R. L. (PD/PI)

  University of Minnesota, Chiron Corporation

  2/18/03 → 12/31/08

  Project: Research project

• Prot# SILCAAT: A Phase III Multicenter Randomized Study of the Biological and Clinical Efficacy of Subcutaneous Recombinant, Human Interleukin-2 in HIV-Infected Patients with Low CD4+ Counts Under Active Antiretroviral Therapy (the "SILCAAT Trial")

  Murphy, R. L. (PD/PI)

  University of Minnesota, Chiron Corporation

  2/18/03 → 12/31/08

  Project: Research project

• Northwestern Adult AIDS Clinical Trials Unit

  Murphy, R. L. (PD/PI), Cohen, B. A. (Co-PD/PI), Garcia, P. M. (Co-PD/PI), Hirschtick, R. E. (Co-PD/PI), Hoff, F. L. (Co-PD/PI), Lowe Jr, W. L. (Co-PD/PI), Palella Jr, F. J. (Co-PD/PI), Pelzer, H. J. (Co-PD/PI), Phair, J. P. (Co-PD/PI), Sutton, S. H. (Co-PD/PI), Wolinsky, S. M. (Co-PD/PI), Cohen, B. A. (Other), Garcia, P. M. (Other), Hirschtick, R. E. (Other), Lowe Jr, W. L. (Other), Palella Jr, F. J. (Other), Pelzer, H. J. (Other), Phair, J. P. (Other) & Wolinsky, S. M. (Other)

  National Institute of Allergy and Infectious Diseases

  1/1/00 → 12/31/07

  Project: Research project

• Northwestern Adult AIDS Clinical Trials Unit

  Murphy, R. L. (PD/PI), Cohen, B. A. (Co-PD/PI), Garcia, P. M. (Co-PD/PI), Hirschtick, R. E. (Co-PD/PI), Hoff, F. L. (Co-PD/PI), Lowe Jr, W. L. (Co-PD/PI), Palella Jr, F. J. (Co-PD/PI), Pelzer, H. J. (Co-PD/PI), Phair, J. P. (Co-PD/PI), Sutton, S. H. (Co-PD/PI), Wolinsky, S. M. (Co-PD/PI), Cohen, B. A. (Other), Garcia, P. M. (Other), Hirschtick, R. E. (Other), Lowe Jr, W. L. (Other), Palella Jr, F. J. (Other), Pelzer, H. J. (Other), Phair, J. P. (Other) & Wolinsky, S. M. (Other)

  National Institute of Allergy and Infectious Diseases

  1/1/00 → 12/31/07

  Project: Research project

• Study of the Ocular Complications of AIDS (SOCA)

  Lyon, A. (PD/PI), Jampol, L. M. (Other) & Murphy, R. L. (Other)

  Johns Hopkins University, National Eye Institute

  8/1/98 → 7/31/10

  Project: Research project

• Study of the Ocular Complications of AIDS (SOCA) Patient Care

  Lyon, A. (PD/PI), Lyon, A. (Other) & Murphy, R. L. (Other)

  Johns Hopkins University, National Eye Institute

  8/1/98 → 7/31/08

  Project: Research project

• Study of the Ocular Complications of AIDS (SOCA)

  Lyon, A. (PD/PI), Jampol, L. M. (Other) & Murphy, R. L. (Other)

  Johns Hopkins University, National Eye Institute

  8/1/98 → 7/31/10

  Project: Research project

• Protocol # CS-L2004C: A Multi-Center Compassionate Use Protocol for Proleukin (Aldesleukin) and Antiretroviral Therapy in HIV Seropositive Patients Who Have Successfully Completed a Chiron-Sponsored Proleukin Trial

  Murphy, R. L. (PD/PI)

  Chiron Corporation

  1/26/98 → 8/12/08

  Project: Research project

• Protocol # CS-L2004C: A Multi-Center Compassionate Use Protocol for Proleukin (Aldesleukin) and Antiretroviral Therapy in HIV Seropositive Patients Who Have Successfully Completed a Chiron-Sponsored Proleukin Trial

  Murphy, R. L. (PD/PI)

  Chiron Corporation

  1/26/98 → 8/12/08

  Project: Research project

• Supplemental Funding for the Northwestern Adult AIDS Clinical Trials Group

  Murphy, R. L. (PD/PI)

  Social & Scientific Systems, Inc.

  1/1/98 → 4/10/07

  Project: Research project

• Supplemental Funding for the Northwestern Adult AIDS Clinical Trials Group

  Murphy, R. L. (PD/PI)

  Social & Scientific Systems, Inc.

  1/1/98 → 4/10/07

  Project: Research project

• Protocol # M97-720: Phase I/II Study of ABT-378/Ritonavir in Combination with Reverse Transcriptase Inhibitors in Antiretroviral Naive HIV-Infected Patients

  Murphy, R. L. (PD/PI)

  PPD Development, Abbott Laboratories

  11/7/97 → 6/23/06

  Project: Research project